
DarioHealth fell 84.2% from $13.01 to $2.06, behind the S&P 500's +10.5%. Its worst day was Apr 7 (−16.5%), and its low came Nov 9 at $2.06.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.91 beat the $-3.03 estimate on $5.0M revenue (est. $5.7M).
−15.6% · S&P 500 −1.7%
DarioHealth shares rose 19.3%, while the S&P 500 rose 0.7%.
Story events cover the past 12 months · Times ET
+19.3%, the year's best day · S&P 500 +0.7%
EPS of $-0.82 beat the $-1.67 estimate on $5.2M revenue (est. $5.1M).
−14.8% · S&P 500 −0.5%
DarioHealth shares fell 16.5%, while the S&P 500 rose 0.0%.
−16.5%, the year's worst day · S&P 500 0.0%
EPS of $-0.95 missed the $-0.90 estimate on $5.6M revenue (est. $5.5M).
−7.4% · S&P 500 +0.6%
DarioHealth shares rose 14.3%, while the S&P 500 fell 0.7%.
+14.3% · S&P 500 −0.7%
EPS of $-0.72 beat the $-0.84 estimate on $5.2M revenue (est. $5.8M).
+0.1% · S&P 500 −0.3%
Where it ended: a close of $2.06 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.54, revenue est. $5.2M).
Nothing in the past 12 months.
All DRIO dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DRIO and SPY from Benzinga historical bars. Not investment advice.